These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6896012)

  • 1. Effect of L-phenylalanine mustard, adriamycin, actinomycin D, and 4'-(9-acridinylamino)methanesulfon-m-anisidide on naturally occurring human spontaneous monocyte-mediated cytotoxicity.
    Kleinerman ES; Zwelling LA; Schwartz R; Muchmore AV
    Cancer Res; 1982 May; 42(5):1692-5. PubMed ID: 6896012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of naturally occurring human spontaneous monocyte-mediated cytotoxicity by cis-diamminedichloroplatinum(II).
    Kleinerman ES; Zwelling LA; Muchmore AV
    Cancer Res; 1980 Sep; 40(9):3099-102. PubMed ID: 6448684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity and DNA strand breaks by 5-iminodaunorubicin in mouse leukemia L1210 cells: comparison with adriamycin and 4'-(9-acridinylamino)methanesulfon-m-anisidide.
    Zwelling LA; Kerrigan D; Michaels S
    Cancer Res; 1982 Jul; 42(7):2687-91. PubMed ID: 6896293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid killing of actinomycin D-treated tumor cells by human monocytes. II. Cytotoxicity is independent of secretion of reactive oxygen intermediates and is suppressed by protease inhibitors.
    Colotta F; Bersani L; Lazzarin A; Poli G; Mantovani A
    J Immunol; 1985 May; 134(5):3524-31. PubMed ID: 4038989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative studies of DNA cross-linking and cytotoxicity in Burkitt's lymphoma cell lines treated with cis-diamminedichloroplatinum(II) and L-phenylalanine mustard.
    Ducore JM; Erickson LC; Zwelling LA; Laurent G; Kohn KW
    Cancer Res; 1982 Mar; 42(3):897-902. PubMed ID: 7199380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug sensitivity and cross-resistance of the 4'-(9-acridinylamino)methanesulfon-m-anisidide-resistant subline of HL-60 human leukemia.
    Odaimi M; Andersson BS; McCredie KB; Beran M
    Cancer Res; 1986 Jul; 46(7):3330-3. PubMed ID: 3754787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of amsacrine and other DNA-intercalating drugs on nuclear and nucleolar structure in cultured V79 Chinese hamster cells and PtK2 rat kangaroo cells.
    Jensen CG; Wilson WR; Bleumink AR
    Cancer Res; 1985 Feb; 45(2):717-25. PubMed ID: 3838148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monocyte cytotoxicity: evidence for multiple mechanisms of in vitro erythrocyte target killing. Trypan blue can both inhibit and enhance target lysis.
    Hall RE; Muchmore AV; Blaese RM
    J Reticuloendothel Soc; 1982 Sep; 32(3):233-46. PubMed ID: 7153988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-cycle-stage specificity of 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) and interaction with ionizing radiation in mammalian cell cultures.
    Wilson WR; Whitmore GF
    Radiat Res; 1981 Jul; 87(1):121-36. PubMed ID: 7019954
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of 4'-(9-acridinylamino) methanesulfon-m-anisidide (m-AMSA, NSC 249992) on human tumors in nude mice.
    Sordillo PP; Helson L; Lesser M
    Cancer Clin Trials; 1980; 3(4):385-9. PubMed ID: 6893575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxygen- and temperature-dependent cytotoxic and radiosensitizing effects of cis-dichlorodiammineplatinum(II) on human NHIK 3025 cells in vitro.
    Melvik JE; Pettersen EO
    Radiat Res; 1988 Jun; 114(3):489-99. PubMed ID: 3375438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo effect of doxorubicin combined with liposome-encapsulated muramyl tripeptide on canine monocyte activation.
    Shi F; MacEwen EG; Kurzman ID
    Cancer Res; 1993 Sep; 53(17):3986-91. PubMed ID: 8358727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lethal activity and kinetic response of cultured human cells to 4'-(9-acridinylamino)methanesulfon-m-anisidine.
    Drewinko B; Yang LY; Barlogie B
    Cancer Res; 1982 Jan; 42(1):107-11. PubMed ID: 6895609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells.
    de Jong S; Kooistra AJ; de Vries EG; Mulder NH; Zijlstra JG
    Cancer Res; 1993 Mar; 53(5):1064-71. PubMed ID: 8382551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity of 4'-(9-acridinylamino)methanesulfon-m-anisidide in exponential- and plateau-phase Chinese hamster cell cultures.
    Wilson WR; Giesbrecht JL; Hill RP; Whitmore GF
    Cancer Res; 1981 Jul; 41(7):2809-16. PubMed ID: 6894713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I-II study of m-AMSA administered as a continuous infusion.
    Micetich KC; Zwelling LA; Gormley P; Young RC
    Cancer Treat Rep; 1982 Oct; 66(10):1813-7. PubMed ID: 6897013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of the bacteriophage T4 type II DNA topoisomerase that alter sensitivity to antitumor agent 4'-(9-acridinylamino)methanesulfon-m-anisidide and an antibacterial quinolone.
    Freudenreich CH; Chang C; Kreuzer KN
    Cancer Res; 1998 Mar; 58(6):1260-7. PubMed ID: 9515814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of Fas-mediated apoptosis in renal cell carcinoma cells by adriamycin.
    Wu XX; Mizutani Y; Kakehi Y; Yoshida O; Ogawa O
    Cancer Res; 2000 Jun; 60(11):2912-8. PubMed ID: 10850437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro chemosensitivities of human tumor stem cells to the Phase II drug 4'-(9-acridinylamino)methanesulfon-m-anisidide and prospective in vivo correlations.
    Ahmann FR; Meyskens FL; Moon TE; Durie BG; Salmon SE
    Cancer Res; 1982 Nov; 42(11):4495-8. PubMed ID: 6897012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo effect of adriamycin therapy on monocyte activation by liposome-encapsulated immunomodulators.
    Hudson MM; Snyder JS; Jaffe N; Kleinerman ES
    Cancer Res; 1988 Sep; 48(18):5256-63. PubMed ID: 3261632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.